SCHEMBL3296971

SCHEMBL3296971

CCOc1ccc([SiH](O[SiH](c2ccc(OCC)cc2OCC)c2ccc(OCC)cc2OCC)c2ccc(OCC)cc2OCC)c(OCC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
NQO1 P15559 1/20 0.46
LTA4H P09960 2/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
TSHR P16473 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 4/20 0.39
CYP3A4 P08684 2/20 0.39
MAPT P10636 3/20 0.39
HSD17B10 Q99714 3/20 0.39
ALDH1A1 P00352 3/20 0.39
ESR2 Q92731 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
BRCA1 P38398 1/20 0.38
HBB P68871 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3297866 0.87 NQO1 (0.48) KDM4ENQO1LTA4HKMT2AMEN1
SCHEMBL3295354 0.82 LTA4H (0.43) LTA4HKMT2AMEN1NPC1TSHR
SCHEMBL3296786 0.81 NQO1 (0.46) KDM4ENQO1LTA4HKMT2AMEN1
SCHEMBL3296081 0.81 MAPT (0.44) KDM4EKMT2AMEN1NPC1TSHR
SCHEMBL3296571 0.80 CALM1 (0.37) KDM4EKMT2AMEN1TSHRTDP1
SCHEMBL3300274 0.80 NQO1 (0.45) KDM4ENQO1LTA4HKMT2AMEN1
SCHEMBL3302637 0.78 TSHR (0.44) KDM4ENQO1KMT2AMEN1TSHR
SCHEMBL3301870 0.78 NQO1 (0.46) KDM4ENQO1LTA4HKMT2AMEN1
SCHEMBL3296126 0.77 ALDH1A1 (0.40) KDM4EKMT2AMEN1TDP1TP53
SCHEMBL3296595 0.77 NQO1 (0.42) KDM4ENQO1LTA4HKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 KDM4E 1578/4885NQO1 3910/4885LTA4H 1866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.